These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 17563034)

  • 1. Treatment of MRSA infections with older molecules: a reasonable option for investigation.
    Hmouda H; Ben Salem C; Bouraoui K; Jemni L
    Arch Intern Med; 2007 Jun; 167(11):1207-8; author reply 1208-9. PubMed ID: 17563034
    [No Abstract]   [Full Text] [Related]  

  • 2. [Nosocomial methicillin-resistant staphylococci that remain sensitive to non-beta lactam antibiotics].
    Manfredi R; Nanetti A; Morelli S; Valentini R; Ferri M; Calza L; Chiodo F
    Recenti Prog Med; 2003; 94(7-8):344. PubMed ID: 12868245
    [No Abstract]   [Full Text] [Related]  

  • 3. Trimethoprim-sulfamethoxazole as a viable treatment option for infections caused by methicillin-resistant Staphylococcus aureus.
    Grim SA; Rapp RP; Martin CA; Evans ME
    Pharmacotherapy; 2005 Feb; 25(2):253-64. PubMed ID: 15767239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comment on: Bactericidal activity of orally available agents against methicillin-resistant Staphylococcus aureus.
    Hmouda H; Ben Salem C; Bouraoui K; Jemni L
    J Antimicrob Chemother; 2006 Dec; 58(6):1307; author reply 1307-8. PubMed ID: 17056611
    [No Abstract]   [Full Text] [Related]  

  • 5. Alternatives to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections.
    Micek ST
    Clin Infect Dis; 2007 Sep; 45 Suppl 3():S184-90. PubMed ID: 17712745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comment: Trimethoprim/sulfamethoxazole for treatment of severe Staphylococcus aureus infections.
    Hmouda H; Jemni L
    Ann Pharmacother; 2004 Nov; 38(11):1970-1; author reply 1971-2. PubMed ID: 15466908
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of folate antagonists in the treatment of methicillin-resistant Staphylococcus aureus infection.
    Proctor RA
    Clin Infect Dis; 2008 Feb; 46(4):584-93. PubMed ID: 18197761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methicillin-resistant Staphylococcus aureus: a community concern.
    Hedge DD
    S D Med; 2006 Oct; 59(10):433, 435. PubMed ID: 17124921
    [No Abstract]   [Full Text] [Related]  

  • 9. Methicillin-resistant Staphylococcus aureus infections.
    Abrahamian FM; Moran GJ
    N Engl J Med; 2007 Nov; 357(20):2090; author reply 2090. PubMed ID: 18003971
    [No Abstract]   [Full Text] [Related]  

  • 10. Alternative agents for the treatment of invasive infections due to methicillin-resistant Staphylococcus aureus strains with reduced susceptibility to vancomycin.
    Tattevin P; Arvieux C; Michelet C
    Arch Intern Med; 2007 Jun; 167(11):1206; author reply 1208-9. PubMed ID: 17563033
    [No Abstract]   [Full Text] [Related]  

  • 11. Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains.
    Sakoulas G; Moellering RC
    Clin Infect Dis; 2008 Jun; 46 Suppl 5():S360-7. PubMed ID: 18462091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trimethoprim/sulfamethoxazole for treatment of severe Staphylococcus aureus infections.
    Adra M; Lawrence KR
    Ann Pharmacother; 2004 Feb; 38(2):338-41. PubMed ID: 14742775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Staphylococcus aureus bloodstream infections: definitions and treatment.
    Corey GR
    Clin Infect Dis; 2009 May; 48 Suppl 4():S254-9. PubMed ID: 19374581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postpartum iliopsoas pyomyositis due to community-acquired methicillin-resistant Staphylococcus aureus.
    Sokolov KM; Kreye E; Miller LG; Choi C; Tang AW
    Obstet Gynecol; 2007 Aug; 110(2 Pt 2):535-8. PubMed ID: 17666656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic therapy of methicillin-resistant Staphylococcus aureus in critical care.
    Tverdek FP; Crank CW; Segreti J
    Crit Care Clin; 2008 Apr; 24(2):249-60, vii-viii. PubMed ID: 18361944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Burden of methicillin-resistant Staphylococcus aureus: focus on clinical and economic outcomes.
    Lodise TP; McKinnon PS
    Pharmacotherapy; 2007 Jul; 27(7):1001-12. PubMed ID: 17594206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of severe infections caused by Staphylococcus aureus: a change in the vancomycin paradigm?
    Aranha Camargo LF
    Shock; 2008 Oct; 30 Suppl 1():67-9. PubMed ID: 18704006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Key considerations in the treatment of complicated staphylococcal infections.
    Jones RN
    Clin Microbiol Infect; 2008 Mar; 14 Suppl 2():3-9. PubMed ID: 18226084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure of vancomycin for treatment of methicillin-resistant Staphylococcus aureus infections.
    Howden BP; Johnson PD; Charles PG; Grayson ML
    Clin Infect Dis; 2004 Nov; 39(10):1544; author reply 1544-5. PubMed ID: 15546096
    [No Abstract]   [Full Text] [Related]  

  • 20. [Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA)--a new challenge in the ambulatory setting?].
    Buehlmann M; Chuard C
    Rev Med Suisse; 2007 Oct; 3(128):2289-90, 2292-3. PubMed ID: 17985605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.